Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine SR 2mg vs 4mg with Doxazosin in Men with OAB and BPO
NCT00922506Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- May 2009
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in overactive bladder (OAB), sponsored by Samsung Medical Center. Started May 2009; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00922506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922506.